MaineC.J., Miyake-StonerS.J., SpasovaD.S.et al.Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers. Nat Commun., 2025; 16(1). doi.org/10.1038/s41467-025-55843-9
